VANCOUVER, BRITISH COLUMBIA--(Marketwired - Dec. 8, 2016) -


Emblem Corp. (the "Company") (TSX VENTURE:EMC), formerly Saber Capital Corp. (TSX VENTURE:SAB.H), would like to correct an error in its December 7, 2016 press release. In such release, it was incorrectly stated that, upon commencement of trading, the Company would trade under the ticker symbol "EMP". This information was provided in error.

When the common shares of the Company resume trading on the TSX Venture Exchange, they will resume trading under the new ticker symbol "EMC" once the Exchange's conditions for listing are satisfied and the Exchange issues its final exchange bulletin confirming the completion of the Company's Qualifying Transaction.

About Emblem

Emblem is licensed under the Access to Cannabis for Medical Purposes Regulations (the "ACMPR") to cultivate and sell medical marihuana. Emblem carries out its principal activities producing marihuana from its facilities in Paris, Ontario pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada) and its regulations.

The TSX Venture Exchange Inc. has in no way passed upon the merits of the Qualifying Transaction and has neither approved nor disapproved the contents of this press release.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release contains forward-looking information, which involves known and unknown risks, uncertainties and other factors that may cause actual events to differ materially from current expectation. Emblem cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond Emblem's control. Such factors include those described in the Filing Statement filed with the Canadian Securities Administrators and available on Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward looking information. Except as required under applicable securities legislation, Saber undertakes no obligation to publicly update or revise forward-looking information.

A halt in trading shall remain in place until after the Qualifying Transaction is completed or such time that acceptable documentation is filed with the Exchange.

Contact Information:

Danny Brody Director
Investor Relations
Emblem Corp.
(647) 255-8106